Stockreport

Galecto Announces Pricing of $275 Million Underwritten Public Offering

Galecto, Inc.  (GLTO) 
PDF BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment [Read more]